Is UFP Technologies (UFPT) overvalued or fairly valued?

MarketChacha shows UFP Technologies's valuation in context — a trailing P/E of about 31.1, a forward P/E of about 24.3, a price-to-book of about 5.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does UFP Technologies's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.16×) from reported figures — education, not a rating.

What is UFP Technologies's revenue?

UFP Technologies reported revenue of $602.8M for FY2025, with net profit of $68.3M, per official filings.

What is the share price of UFP Technologies (UFPT)?

UFP Technologies last traded at $288.79 (+0.8% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

UFP Technologies

UFPT · NYSE · Healthcare · United States

Snapshot

TickerUFPT

ExchangeNYSE

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees4,846

HeadquartersNewburyport, United States

Websitewww.ufpt.com

Filings tracked21

About UFP Technologies

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Who owns it

Insiders3.8%
Institutions96.2%
Public & other0.0%

385 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.14.74%
Congress Asset Management Co8.88%
Wasatch Advisors LP8.82%
Neuberger Berman Group, LLC6.93%
Price (T.Rowe) Associates Inc4.61%
Boston Trust Walden Corporation4.34%
Vanguard Capital Management LLC4.26%
State Street Corporation4.04%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.16×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend11.2% → 11.3%

Margin has held broadly steady over the period — stable profitability.

Return on equity16.1%

Latest ROE of 16.1% — capital is generating a healthy return.

Growth qualityrev 23% · PAT 23%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $162.7M · EPS 2.54

Est. earnings growth +4.0%

Next fiscal year

Rev $698.9M · EPS 11.87

Est. earnings growth +11.8%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$602.8M

Net margin

11.3%

ROE

16.1%

Revenue CAGR (2y)

+22.7%

Profit CAGR (2y)

+23.3%

EPS (FY2025)

8.75

Net profit (FY2025)

$68.3M

Ask MarketChacha about UFPT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$602.8M	$68.3M	8.75	11.3%	16.1%
FY2024	$504.4M	$59.0M	7.58	11.7%	17.2%
FY2023	$400.1M	$44.9M	5.83	11.2%	15.7%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$174.0M	$20.9M	2.68	12.0%
2026Q1	$154.2M	$17.5M	2.24	11.3%
2025Q4	$148.9M	$17.6M	2.25	11.8%
2025Q3	$154.6M	$16.4M	2.11	10.6%
2025Q2	$151.2M	$17.2M	2.21	11.4%
2025Q1	$148.1M	$17.2M	2.21	11.6%
2024Q4	$144.1M	$16.4M	2.10	11.4%
2024Q3	$145.2M	$16.4M	2.11	11.3%
2024Q2	$110.2M	$13.6M	1.75	12.3%
2024Q1	$105.0M	$12.7M	1.64	12.1%
2023Q4	$101.5M	$11.6M	1.51	11.4%
2023Q3	$100.8M	$11.7M	1.52	11.6%
2023Q2	$100.0M	$11.9M	1.55	11.9%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/6/2026
8-K — Results of operations, Exhibits
SEC8/3/2026material
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC6/10/2026material
8-K — Reg FD disclosure, Exhibits
SEC6/8/2026material
8-K — Shareholder vote results
SEC6/5/2026material
8-K — Executive/director change
SEC5/26/2026material
10-Q filing
SEC5/8/2026
8-K — Results of operations, Exhibits
SEC5/4/2026material
8-K — Reg FD disclosure, Exhibits
SEC2/27/2026material
10-K filing
SEC2/27/2026
8-K — Results of operations, Exhibits
SEC2/24/2026material
8-K filing
SEC2/24/2026material
8-K — Material agreement, Exhibits
SEC2/24/2026material
8-K — Executive/director change, Exhibits
SEC2/13/2026material

2025

8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC12/2/2025material
8-K — Reg FD disclosure, Exhibits
SEC12/2/2025material
10-Q filing
SEC11/7/2025
8-K — Results of operations, Exhibits
SEC11/3/2025material
8-K — Reg FD disclosure, Exhibits
SEC8/21/2025material
10-Q — FORM 10-Q
SEC8/11/2025
8-K — Results of operations, Exhibits
SEC8/5/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.